Detalles de la búsqueda
1.
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.
Blood
; 130(15): 1713-1721, 2017 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28830889
2.
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.
Proc Natl Acad Sci U S A
; 107(31): 13824-9, 2010 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20631300
3.
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.
Oncologist
; 17(2): 250-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22291091
4.
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.
Cytotherapy
; 11(5): 653-68, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19530029
5.
Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells.
J Immunol
; 169(4): 1669-75, 2002 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12165485
Resultados
1 -
5
de 5
1
Próxima >
>>